Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

OTSSP167 (hydrochloride)

OTSSP167 (OTS167) hydrochloride is a highly potent and ATP-competitive MELK inhibitor with IC50 value of 0.41 nM.

Product Specifications

CAS Number

[1431698-10-0]

Product Name Alternative

OTS167 (hydrochloride)

UNSPSC

12352005

Hazard Statement

H302, H315, H319

Target

MELK

Type

Reference compound

Related Pathways

PI3K/Akt/mTOR

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/OTSSP167-hydrochloride.html

Purity

99.78

Solubility

DMSO : 33.33 mg/mL (ultrasonic) |H2O : 7.14 mg/mL (ultrasonic)

Smiles

ClC1=CC(C2=CC=C(N=CC(C(C)=O)=C3N[C@H]4CC[C@H](CN(C)C)CC4)C3=N2)=CC(Cl)=C1O.[H]Cl

Molecular Formula

C25H29Cl3N4O2

Molecular Weight

523.88

Precautions

H302, H315, H319

References & Citations

[1]Chung S, Suzuki H, Miyamoto T, et al. Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. Oncotarget. 2012 Dec 21.|[2]Ji W, et al. OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases. PLoS One. 2016 Apr 15;11 (4) :e0153518.|[3]Cho YS, et al. The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor. Biochem Biophys Res Commun. 2014 Apr 25;447 (1) :7-11.|[4]Jurmeister S, et al. Identification of potential therapeutic targets in prostate cancer through a cross-species approach. EMBO Mol Med. 2018 Feb 5. pii: e8274.|[5]Meel MH, et al. MELK inhibition in Diffuse Intrinsic Pontine Glioma. Clin Cancer Res. 2018 Jul 30. pii: clincanres.0924.2018.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

Phase 2

Citation 01

Clin Cancer Res. 2018 Nov 15;24 (22) :5645-5657. |Elife. 2017 Mar 24;6:e24179.|Elife. 2018 Feb 8;7:e32838. |EMBO Mol Med. 2018 Mar;10 (3) . pii: e8274.|Free Radic Biol Med. 2021 Aug 20:172:312-329.|Gynecol Oncol. 2017 Apr;145 (1) :159-166.|Harvard Medical School LINCS LIBRARY|Int J Mol Sci. 2025 Mar 3;26 (5) :2245.|Nat Cancer. 2024 Aug;5 (8) :1250-1266.|Neuro Oncol. 2020 Jan 11;22 (1) :58-69. |University of Washington. 2025.|Adv Ther (Weinh) . 2025 Oct 24.|Biochem Biophys Res Commun. 2014 Apr 25;447 (1) :7-11. |Blood Cancer J. 2019 Nov 18;9 (12) :87.|Eur J Pharmacol. 2025 Oct 5:1004:178017.|Int J Oncol. 2022 Jul;61 (1) :89.|Mol Cancer. 2014 May 4;13:100.|Oncotarget. 2016 Feb 2;7 (5) :6266-80. |Oncotarget. 2017 Dec 20;9 (2) :2591-2602. |Patent. US20160291017A1.|PLoS One. 2017 Feb 24;12 (2) :e0172832. |Sci Rep. 2017 Feb 14;7:42502.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Nth Endonuclease III-Like 1 Human Recombinant (NTHL1 Human)
NOV-PT_72867-2ug 2 µg

Nth Endonuclease III-Like 1 Human Recombinant (NTHL1 Human)

Ask
View Details
GPALPP1 Knockout MES-OV Polyclonal Cells
ARG24457 1 Million

GPALPP1 Knockout MES-OV Polyclonal Cells

Ask
View Details
Chordin (CHRD) Rabbit Polyclonal Antibody
TA369975 100 µL

Chordin (CHRD) Rabbit Polyclonal Antibody

Ask
View Details
Rabbit Polyclonal GGT1 Antibody
NBP1-32412 100 µL

Rabbit Polyclonal GGT1 Antibody

Ask
View Details
SNORD74 CRISPRa sgRNA lentivector (set of three targets)(Human)
44923121 3x 1.0µg DNA

SNORD74 CRISPRa sgRNA lentivector (set of three targets)(Human)

Ask
View Details